Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria‐Evangelia Adami"'
Autor:
Alexi, Vasbinder, Elizabeth, Anderson, Husam, Shadid, Hanna, Berlin, Michael, Pan, Tariq U, Azam, Ibrahim, Khaleel, Kishan, Padalia, Chelsea, Meloche, Patrick, O'Hayer, Erinleigh, Michaud, Tonimarie, Catalan, Rafey, Feroze, Pennelope, Blakely, Christopher, Launius, Yiyuan, Huang, Lili, Zhao, Lynn, Ang, Monica, Mikhael, Kara, Mizokami-Stout, Subramaniam, Pennathur, Matthias, Kretzler, Sven H, Loosen, Athanasios, Chalkias, Frank, Tacke, Evangelos J, Giamarellos-Bourboulis, Jochen, Reiser, Jesper, Eugen-Olsen, Eva L, Feldman, Rodica, Pop-Busui, Salim S, Hayek, Kishan J, Padalia, Danny, Perry, Abbas, Bitar, Rayan, Kaakati, Beata, Samelko, Alex, Hlepas, Priya P, Patel, Xuexiang, Wang, Izzet, Altintas, Marius, Stauning, Morten, Baltzer Houlind, Mette B, Lindstrøm, Hejdi, Gamst-Jensen, Line Jee, Hartmann, Jan O, Nehlin, Thomas, Kallemose, Imran, Parvaiz, Christian, Rasmussen, Ove, Andersen, Jens, Tingleff, Maria-Evangelia, Adami, Nicky, Solomonidi, Maria, Tsilika, Maria, Saridaki, Vasileios, Lekakis, Tom, Luedde, Verena, Keitel, Eleni, Arnaoutoglou, Ioannis, Pantazopoulos, Eleni, Laou, Konstantina, Kolonia, Anargyros, Skoulakis, Pinkus, Tober-Lau, Raphael, Mohr, Florian, Kurth, Leif Erik, Sander, Christoph, Jochum
Publikováno v:
Diabetes Care
OBJECTIVE Diabetes mellitus (DM) is a major risk factor for severe coronavirus disease 2019 (COVID-19) for reasons that are unclear. RESEARCH DESIGN AND METHODS We leveraged the International Study of Inflammation in COVID-19 (ISIC), a multicenter ob
Autor:
Shengyuan Luo, Alexi Vasbinder, Jeanne M. Du‐Fay‐de‐Lavallaz, Joanne Michelle D. Gomez, Tisha Suboc, Elizabeth Anderson, Annika Tekumulla, Husam Shadid, Hanna Berlin, Michael Pan, Tariq U. Azam, Ibrahim Khaleel, Kishan Padalia, Chelsea Meloche, Patrick O'Hayer, Tonimarie Catalan, Pennelope Blakely, Christopher Launius, Kingsley‐Michael Amadi, Rodica Pop‐Busui, Sven H. Loosen, Athanasios Chalkias, Frank Tacke, Evangelos J. Giamarellos‐Bourboulis, Izzet Altintas, Jesper Eugen‐Olsen, Kim A. Williams, Annabelle Santos Volgman, Jochen Reiser, Salim S. Hayek, Kingsley Amadi, Patrick O’Hayer, Rafey Feroze, Kishan J. Padalia, Danny Perry, Abbas Bitar, Rayan Kaakati, Lili Zhao, Peiyao Zhao, Erinleigh Michaud, Yiyuan Huang, Toniemarie Catalan, Beata Samelko, Alexander Hlepas, Xuexiang Wang, Priya Patel, Jens Tingleff, Marius Stauning, Morten Baltzer Houlind, Mette B. Lindstrøm, Ove Andersen, Hejdi Gamst‐Jensen, Line Jee Hartmann Rasmussen, Christian Rasmussen, Jan O. Nehlin, Thomas Kallemose, Imran Parvaiz, Maria‐Evangelia Adami, Nicky Solomonidi, Maria Tsilika, Maria Saridaki, Vasileios Lekakis, Sven Loosen, Tom Luedde, Verena Keitel, Ioannis Pantazopoulos, Eleni Laou, Anargyros Skoulakis, Pinkus Tober‐Lau, Raphael Mohr, Florian Kurth, Leif Erik Sander, Christoph Jochum, Philipp Koehler
Publikováno v:
Journal of the American Heart Association. 11
Background Venous thromboembolism (VTE) contributes significantly to COVID‐19 morbidity and mortality. The urokinase receptor system is involved in the regulation of coagulation. Levels of soluble urokinase plasminogen activator receptor (suPAR) re
Autor:
Hans J. P. M. Koenen, Evdoxia Kyriazopoulou, Reinout van Crevel, Georgia Damoraki, Mihai G. Netea, Athanassios Karageorgos, Theologia Gkavogianni, Amalia Bolanou, Nikolaos Antonakos, Dionyssia-Irene Droggiti, Antonios Papadopoulos, George Renieris, Jorge Domínguez-Andrés, Maria Tsilika, Antigone Kotsaki, Evangelos J. Giamarellos-Bourboulis, Simone J.C.F.M. Moorlag, Maria-Evangelia Adami, Panagiotis Koufargyris
Publikováno v:
Cell
Cell, 183, 2, pp. 315-323
Cell, 183, 315-323
Cell, 183, 2, pp. 315-323
Cell, 183, 315-323
BCG vaccination in children protects against heterologous infections and improves survival independently of tuberculosis prevention. The phase III ACTIVATE trial assessed whether BCG has similar effects in the elderly. In this double-blind, randomize
Autor:
Dimitrios Sinapidis, Stamatios Halvatzis, Aggelos Stefos, Evdoxia Kyriazopoulou, Malvina Lada, Pantelis Koutoukas, Vasilios Kosmas, Nikolaos Alexiou, Anna Makina, Aikaterini Kyprianou, Michael S. Niederman, Anna Kyriakoudi, Maria Pavlaki, Charalambos Gogos, Evangelos J. Giamarellos-Bourboulis, Dimitrios Velissaris, Maria-Evangelia Adami, Miltiades Kyprianou
Publikováno v:
International journal of antimicrobial agents. 55(1)
Although analysis of retrospective studies has documented survival benefit from the addition of a macrolide to the treatment regimen for community-acquired pneumonia (CAP), no data are available to determine if there is differential efficacy between
Autor:
Eleni Karakike, Maria-Evangelia Adami, Malvina Lada, Theologia Gkavogianni, Ioannis M. Koutelidakis, Michael Bauer, Evangelos J. Giamarellos-Bourboulis, Iraklis Tsangaris
Publikováno v:
SHOCK
Autor:
Vassiliki Panou, Antigone Kotsaki, Mihai G. Netea, Vasileios Lekakis, Nikolaos Koulouris, Theologia Gkavogianni, George Renieris, Panagiotis Koufargyris, Antonia Koutsoukou, Georgia Damoraki, Konstantina Katrini, Maria Evangelia Adami, Nikoletta Rovina, Mihaela Lupse, Maria Ntaganou, Dimitrios Velissaris, George Dimopoulos, Nikolaos Antonakos, Karolina Akinosoglou, Ioannis Koutsodimitropoulos, Evangelos J. Giamarellos-Bourboulis, Evangelia Koukaki, Charalambos Gogos, Magdalini Kyriakopoulou, Paraskevi Katsaounou, Danai Theodoulou, Anastasia Antoniadou, Athanassios Karageorgos
Publikováno v:
Cell Host & Microbe
Cell Host & Microbe, 27, 6, pp. 992-1000.e3.
Cell Host & Microbe, 27, 992-1000.e3.
Cell Host & Microbe, 27, 6, pp. 992-1000.e3.
Cell Host & Microbe, 27, 992-1000.e3.
Proper management of COVID-19 mandates better understanding of disease pathogenesis. The sudden clinical deterioration 7-8 days after initial symptom onset suggests that severe respiratory failure (SRF) in COVID-19 is driven by a unique pattern of im
Autor:
Eleni Karakike, Evangelos J. Giamarellos-Bourboulis, Theologia Gkavogianni, Ioannis Koutelidakis, Iraklis Tsangaris, Michael Bauer, Maria-Evangelia Adami, Malvina Lada
Publikováno v:
Shock. 52(3):334-339
High mobility group box 1 (HMGB1) is released from macrophages as a late biomarker of sepsis. Conditions associated with pre-existing macrophage activation may modify HMGB1 expression. This study aimed to assess the impact of HMGB1 kinetics on 28-day